Novel evidence that the ABO blood group shapes erythropoiesis and results in higher hematocrit for blood group B carriers
© 2023. The Author(s)..
The ABO blood group (BG) system is of great importance for blood transfusion and organ transplantation. Since the same transcription factors (TFs) and microRNAs (miRNAs) govern the expression of ABO BG antigens and regulate erythropoiesis, we hypothesized functional connections between both processes. We found significantly higher hemoglobin and hematocrit values in BG B blood donors compared to BG A. Furthermore, we observed that erythropoiesis in BG B hematopoietic stem/progenitor cells (HSPCs) was accelerated compared to BG A HSPCs. Specifically, BG B HSPCs yielded more lineage-specific progenitors in a shorter time (B: 31.3 ± 2.2% vs. A: 22.5 ± 3.0%). Moreover, non-BG A individuals exhibited more terminally differentiated RBCs with higher enucleation rates containing more hemoglobin compared to BG A. Additionally, we detected increased levels of miRNA-215-5p and -182-5p and decreased expression of their target TFs RUNX1 and HES-1 mRNAs in erythroid BG B precursor cells compared to BG A. This highlights the important roles of these factors for the disappearance of differentiation-specific glycan antigens and the appearance of cancer-specific glycan antigens. Our work contributes to a deeper understanding of erythropoiesis gene regulatory networks and identifies its interference with BG-specific gene expression regulations particularly in diseases, where ABO BGs determine treatment susceptibility and disease progression.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
---|---|
Enthalten in: |
Leukemia - 37(2023), 5 vom: 28. Mai, Seite 1126-1137 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kronstein-Wiedemann, Romy [VerfasserIn] |
---|
Links: |
---|
Themen: |
ABO Blood-Group System |
---|
Anmerkungen: |
Date Completed 11.05.2023 Date Revised 19.09.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41375-023-01858-4 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM353608041 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM353608041 | ||
003 | DE-627 | ||
005 | 20231226060410.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41375-023-01858-4 |2 doi | |
028 | 5 | 2 | |a pubmed24n1178.xml |
035 | |a (DE-627)NLM353608041 | ||
035 | |a (NLM)36854778 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kronstein-Wiedemann, Romy |e verfasserin |4 aut | |
245 | 1 | 0 | |a Novel evidence that the ABO blood group shapes erythropoiesis and results in higher hematocrit for blood group B carriers |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.05.2023 | ||
500 | |a Date Revised 19.09.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s). | ||
520 | |a The ABO blood group (BG) system is of great importance for blood transfusion and organ transplantation. Since the same transcription factors (TFs) and microRNAs (miRNAs) govern the expression of ABO BG antigens and regulate erythropoiesis, we hypothesized functional connections between both processes. We found significantly higher hemoglobin and hematocrit values in BG B blood donors compared to BG A. Furthermore, we observed that erythropoiesis in BG B hematopoietic stem/progenitor cells (HSPCs) was accelerated compared to BG A HSPCs. Specifically, BG B HSPCs yielded more lineage-specific progenitors in a shorter time (B: 31.3 ± 2.2% vs. A: 22.5 ± 3.0%). Moreover, non-BG A individuals exhibited more terminally differentiated RBCs with higher enucleation rates containing more hemoglobin compared to BG A. Additionally, we detected increased levels of miRNA-215-5p and -182-5p and decreased expression of their target TFs RUNX1 and HES-1 mRNAs in erythroid BG B precursor cells compared to BG A. This highlights the important roles of these factors for the disappearance of differentiation-specific glycan antigens and the appearance of cancer-specific glycan antigens. Our work contributes to a deeper understanding of erythropoiesis gene regulatory networks and identifies its interference with BG-specific gene expression regulations particularly in diseases, where ABO BGs determine treatment susceptibility and disease progression | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a ABO Blood-Group System |2 NLM | |
650 | 7 | |a MicroRNAs |2 NLM | |
650 | 7 | |a MIRN215 microRNA, human |2 NLM | |
700 | 1 | |a Blecher, Sarah |e verfasserin |4 aut | |
700 | 1 | |a Teichert, Madeleine |e verfasserin |4 aut | |
700 | 1 | |a Schmidt, Laura |e verfasserin |4 aut | |
700 | 1 | |a Thiel, Jessica |e verfasserin |4 aut | |
700 | 1 | |a Müller, Markus M |e verfasserin |4 aut | |
700 | 1 | |a Lausen, Jörn |e verfasserin |4 aut | |
700 | 1 | |a Schäfer, Richard |e verfasserin |4 aut | |
700 | 1 | |a Tonn, Torsten |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Leukemia |d 1989 |g 37(2023), 5 vom: 28. Mai, Seite 1126-1137 |w (DE-627)NLM012593788 |x 1476-5551 |7 nnns |
773 | 1 | 8 | |g volume:37 |g year:2023 |g number:5 |g day:28 |g month:05 |g pages:1126-1137 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41375-023-01858-4 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 37 |j 2023 |e 5 |b 28 |c 05 |h 1126-1137 |